◆英語タイトル:Flexion Therapeutics Inc (FLXN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014064
◆発行会社(調査会社):
GlobalData
◆発行日:2017年11月22日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The company’s products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory properties. It provides FX006, an injectable, intra-articular, sustained release drug to provide long lasting, local analgesia. The company offers FX007, a preclinical, small molecule TrkA receptor antagonist designed to treat post-operative pain. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US.
Flexion Therapeutics Inc (FLXN) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Flexion Therapeutics Raises US$20 Million In Series B Financing 10
Flexion Therapeutics Raises Additional US$13 Million In Series A Financing 12
Licensing Agreements 13
Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 13
Equity Offering 14
Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 14
Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 16
Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 18
Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 20
Flexion Therapeutics Completes IPO For US$74.7 Million 22
Debt Offering 24
Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 24
Acquisition 25
Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 25
Flexion Therapeutics Inc – Key Competitors 26
Flexion Therapeutics Inc – Key Employees 27
Flexion Therapeutics Inc – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Financial Announcements 29
Nov 06, 2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights 29
Aug 08, 2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights 30
May 04, 2017: Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights 31
Mar 09, 2017: Flexion Reports Year-End 2016 Financial Results 32
Nov 07, 2016: Flexion Therapeutics Reports Third Quarter 2016 Financial Results 33
Aug 03, 2016: Flexion Therapeutics Reports Second-Quarter 2016 Financial Results 34
May 12, 2016: Flexion Therapeutics Reports First-Quarter 2016 Financial Results 35
Mar 10, 2016: Flexion Reports Year-End 2015 Financial Results 36
Corporate Communications 37
Jun 28, 2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary 37
Apr 07, 2017: Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer 38
Sep 14, 2016: Flexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors 39
Product News 40
07/10/2017: Flexion Therapeutics: Update on FX101 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List of Tables
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Flexion Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Flexion Therapeutics Raises US$20 Million In Series B Financing 10
Flexion Therapeutics Raises Additional US$13 Million In Series A Financing 12
Flexion Therapeutics Enters into Licensing Agreement with Southwest Research Institute 13
Flexion Therapeutics Prices Public Offering of Shares for USD122.4 Million 14
Flexion Therapeutics Raises USD74.5 Million in Public Offering of Shares 16
Flexion Therapeutics Raises USD82.6 Million in Public Offering of Shares 18
Flexion Therapeutics Raises USD98.5 Million in Public Offering of Shares 20
Flexion Therapeutics Completes IPO For US$74.7 Million 22
Flexion Therapeutics Raises USD201.3 Million in Private Placement of 3.375% Notes Due 2024 24
Sanofi May Acquire Flexion Therapeutics for up to USD1 Billion 25
Flexion Therapeutics Inc, Key Competitors 26
Flexion Therapeutics Inc, Key Employees 27